Added to YB: 2025-10-28
Pitch date: 2025-10-24
RAY-B.ST [bullish]
RaySearch Laboratories AB (publ)
-1.93%
current return
Author Info
Ridire Research is an independent equity research platform focused on actionable, high-conviction long/short equity ideas. We combine fundamental rigor with quantitative structure to identify mispriced opportunities others overlook. Sign up for the newsletter.
Company Info
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide.
Market Cap
SEK 7.2B
Pitch Price
SEK 233.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.12
P/E
32.96
EV/Sales
5.66
Sector
Health Care Technology
Category
growth
RaySearch Laboratories (RAYB) — Software as Infrastructure
RAY-B.ST: Mission-critical radiotherapy software w/ 85% proton therapy market share, 1000+ cancer centers across 46 countries. RayStation creates massive switching costs via deep integration, retraining requirements & regulatory validation. Multi-vendor compatibility moat vs OEM bundling. 20yr data advantage enables ML optimization. Recurring revenue from upgrades as treatment complexity rises.
Read full article (3 min)